title: Cost-effectiveness of methotrexate and Goeckerman therapy: a flawed analysis.
authors.forename: H W
authors.initials: HW
authors.lastname: Lim
authors.forename: T F
authors.initials: TF
authors.lastname: Anderson
authors.forename: M
authors.initials: M
authors.lastname: Douglass
authors.forename: J
authors.initials: J
authors.lastname: Koo
authors.forename: M
authors.initials: M
authors.lastname: Lebwohl
authors.forename: W
authors.initials: W
authors.lastname: Morison
authors.forename: C
authors.initials: C
authors.lastname: Taylor
authors.forename: M
authors.initials: M
authors.lastname: Zanolli
mesh_terms: D003362:Cost-Benefit Analysis; D003879:Dermatologic Agents / Q000191:economics* / Q000627:therapeutic use*; D006801:Humans; D008727:Methotrexate / Q000191:economics* / Q000627:therapeutic use*; D011565:Psoriasis / Q000628:therapy*; D014467:Ultraviolet Therapy / Q000191:economics*
chemical_list: D003879:Dermatologic Agents; D008727:Methotrexate